{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:54:00Z","timestamp":1789498440578,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Swedish government"},{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Renal function and the skeleton are classic target organs in primary hyperparathyroidism (PHPT), affected by the chronic course of the disease. Most patients diagnosed today exhibit mild PHPT, characterized by slight hypercalcemia and no or unspecific symptoms. Concerns have been raised that PHPT could promote deteriorating kidney function and increase cardiovascular risk directly. To examine the effect of parathyroidectomy (PTX) on mild PHPT on renal function and markers for bone turnover, cardiovascular disease (CVD), and vascular inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective randomized controlled trial. ClinicalTrials.gov: NCT00522028.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Eight Scandinavian referral centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>From 1998 to 2005, 191 patients with mild PHPT were included in Sweden, Norway, and Denmark. Of these 150 were included in the present analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Seventy patients were randomized to PTX and 80 to observation without intervention (OBS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measures<\/jats:title>\n                    <jats:p>e-GFR was calculated based on creatinine and cystatin C. Markers of CVD and systemic inflammation: osteoprotegerin, vascular cell adhesion molecule 1, soluble CD40 ligand, interleukin-1 receptor antagonist, von Willebrand factor. Bone turnover markers: C-terminal telopeptide of type 1 collagen (CTX-1) and serum Procollagen type 1 N-terminal propeptide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No differences in the development of renal function or vascular and systemic inflammation were detected. CTX-1 was lower in PTX after 10 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>Secondary analyses of a randomized controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PTX does not appear to affect renal function or markers of CVD and vascular inflammation in mild PHPT in a ten-year perspective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae109","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T07:36:57Z","timestamp":1724744217000},"page":"354-360","source":"Crossref","is-referenced-by-count":11,"title":["No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-884X","authenticated-orcid":false,"given":"Ansgar","family":"Heck","sequence":"first","affiliation":[{"name":"Section of Specialized Endocrinology, Division of Medicine, Oslo University Hospital , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9017-5116","authenticated-orcid":false,"given":"Mikkel","family":"Pretorius","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Division of Medicine, Oslo University Hospital , 0424 Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-5195","authenticated-orcid":false,"given":"Karolina","family":"Lundstam","sequence":"additional","affiliation":[{"name":"Department of Radiology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg , 41685 Gothenburg ,","place":["Sweden"]},{"name":"Department of Radiology, Sahlgrenska University Hospital , 41685 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3407-3657","authenticated-orcid":false,"given":"Kristin","family":"Godang","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Division of Medicine, Oslo University Hospital , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-332X","authenticated-orcid":false,"given":"Mikael","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Radiology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg , 41685 Gothenburg ,","place":["Sweden"]},{"name":"Department of Radiology, Sahlgrenska University Hospital , 41685 Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]},{"name":"Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet , 0424 Oslo ,","place":["Norway"]},{"name":"Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway , 9037 Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4610","authenticated-orcid":false,"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Division of Medicine, Oslo University Hospital , 0424 Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"11","key":"2024093003555547300_lvae109-B1","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024093003555547300_lvae109-B2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024093003555547300_lvae109-B3","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024093003555547300_lvae109-B4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J Endocrinol"},{"issue":"4","key":"2024093003555547300_lvae109-B5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/j.1523-1755.2005.00587.x","article-title":"Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone","volume":"68","author":"van Abel","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"2024093003555547300_lvae109-B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.ki.5000148","article-title":"The renal Na+\/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone","volume":"69","author":"Bacic","year":"2006","journal-title":"Kidney Int"},{"issue":"17","key":"2024093003555547300_lvae109-B7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/nejm199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"2024093003555547300_lvae109-B8","first-page":"863","article-title":"Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on","volume":"161","author":"Elvius","year":"1995","journal-title":"Eur J Surg"},{"issue":"8","key":"2024093003555547300_lvae109-B9","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jc.2014-1379","article-title":"Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation?","volume":"99","author":"Hendrickson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024093003555547300_lvae109-B10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement","volume":"114","author":"NIH conference","year":"1991","journal-title":"Ann Intern Med"},{"issue":"12","key":"2024093003555547300_lvae109-B11","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024093003555547300_lvae109-B12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024093003555547300_lvae109-B13","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"(11)","key":"2024093003555547300_lvae109-B14","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024093003555547300_lvae109-B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12902-021-00918-z","article-title":"The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study","volume":"22","author":"Matzen","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2024093003555547300_lvae109-B16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nefro.2018.08.007","article-title":"Does renal function improve after parathyroidectomy in primary hyperparathyroidism? Mejora la funci\u00f3n renal tras la paratiroidectom\u00eda en el hiperparatirodismo primario?","volume":"39","author":"Garc\u00eda-Mart\u00edn","year":"2019","journal-title":"Nefrologia (Engl Ed)"},{"issue":"8","key":"2024093003555547300_lvae109-B17","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024093003555547300_lvae109-B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ejendo\/lvad081","article-title":"Long-term effects of primary hyperparathyroidism and parathyroidectomy on kidney function","volume":"189","author":"Zhu","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024093003555547300_lvae109-B19","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024093003555547300_lvae109-B20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2011.05.010","article-title":"Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism","volume":"218","author":"Schillaci","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"2024093003555547300_lvae109-B21","first-page":"279","article-title":"Endothelial activation markers soluble E-selectin and von Willebrand factor in primary hyperparathyroidism","volume":"25","author":"Lumachi","year":"2011","journal-title":"In Vivo"},{"issue":"12","key":"2024093003555547300_lvae109-B22","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/jbmr.2581","article-title":"PTH signaling in osteoprogenitors is essential for B-lymphocyte differentiation and mobilization","volume":"30","author":"Panaroni","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024093003555547300_lvae109-B23","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024093003555547300_lvae109-B24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1530\/ec-18-0259","article-title":"The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism","volume":"7","author":"Godang","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"2024093003555547300_lvae109-B25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024093003555547300_lvae109-B26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann Intern Med."},{"issue":"3","key":"2024093003555547300_lvae109-B27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/jbmr.4763","article-title":"Positive effect of parathyroidectomy compared to observation on BMD in a randomized controlled trial of mild primary hyperparathyroidism","volume":"38","author":"Lundstam","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024093003555547300_lvae109-B28","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024093003555547300_lvae109-B29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1530\/eje.1.02125","article-title":"Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency","volume":"154","author":"Bollerslev","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"(3)","key":"2024093003555547300_lvae109-B30","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/eje-19-0316","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: unmet therapeutic, educational and scientific needs in parathyroid disorders","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024093003555547300_lvae109-B31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"issue":"1","key":"2024093003555547300_lvae109-B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/jc.2007-0600","article-title":"Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity","volume":"93","author":"Siilin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024093003555547300_lvae109-B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000445450","article-title":"Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease","volume":"134","author":"Glassock","year":"2016","journal-title":"Nephron"},{"issue":"5","key":"2024093003555547300_lvae109-B34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.7326\/M22-2222","article-title":"Estimated effect of parathyroidectomy on long-term kidney function in adults with primary hyperparathyroidism","volume":"176","author":"Seib","year":"2023","journal-title":"Ann Intern Med"},{"issue":"6","key":"2024093003555547300_lvae109-B35","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2024093003555547300_lvae109-B36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1055\/s-0033-1349842","article-title":"Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate","volume":"45","author":"Szymczak","year":"2013","journal-title":"Horm Metab Res"},{"issue":"1","key":"2024093003555547300_lvae109-B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cen.12952","article-title":"Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness","volume":"84","author":"Cansu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024093003555547300_lvae109-B38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","article-title":"The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"72","author":"Yavari","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"2024093003555547300_lvae109-B39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/eje-11-0589","article-title":"Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism","volume":"165","author":"Bollerslev","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024093003555547300_lvae109-B40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bone.2003.06.001","article-title":"Large calcium fluxes that are not related to remodeling exist","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"issue":"1","key":"2024093003555547300_lvae109-B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.4199","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-study)","volume":"36","author":"Pretorius","year":"2021","journal-title":"J Bone Miner Res"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae109\/58933762\/lvae109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/354\/59376251\/lvae109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/354\/59376251\/lvae109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T23:56:29Z","timestamp":1727654189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/3\/354\/7742408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae109","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,27]]}}}